Possibility of brigatinib‐based therapy, or chemotherapy plus anti‐angiogenic treatment after resistance of osimertinib harboring EGFR T790M‐cis‐C797S mutations in lung adenocarcin...

由 Yang, Yaning, Xu, Haiyan, Ma, Li, Yang, Lu, Yang, Guangjian, Zhang, Shuyang, Ai, Xin, Zhang, Shucai, Wang, Yan
出版 2021

A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients

由 Xu, Fei, Xu, Haiyan, Wan, Zhiyi, Yang, Guangjian, Yang, Lu, Wu, Xueying, Song, Jin, Wang, Yan
出版 2022

The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors

由 Yang, Guangjian, Liu, Chengming, Hu, Jiaqi, Sun, Yang, Hu, Peizeng, Liu, Liu, Xu, Haiyan, Li, Dazhou, Li, Weihua, Yang, Yaning, Sun, Nan, He, Jie, Wang, Yan
出版 2022

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2-altered NSCLC: a retrospective real-world POLISH study

由 Yang, Guangjian, Yang, Yaning, Liu, Runze, Li, Weihua, Xu, Haiyan, Hao, Xuezhi, Li, Junling, Xing, Puyuan, Zhang, Shuyang, Ai, Xin, Xu, Fei, Wang, Yan
出版 2022

Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis and Sensitivity to HER2-Targeted Tyrosine Kinase Inhibitors

由 Yang, Guangjian, Xu, Haiyan, Hu, Jiaqi, Liu, Runze, Hu, Peizeng, Yang, Yaning, Li, Weihua, Hao, Xuezhi, Zhang, Shuyang, Xu, Fei, Ai, Xin, Li, Junling, Wang, Yan
出版 2022

Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer

由 Liu, Chengming, Yang, Lu, Xu, Haiyan, Zheng, Sufei, Wang, Zhanyu, Wang, Sihui, Yang, Yaning, Zhang, Shuyang, Feng, Xiaoli, Sun, Nan, Wang, Yan, He, Jie
出版 2022

Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer

由 Liu, Chengming, Yang, Lu, Xu, Haiyan, Zheng, Sufei, Wang, Zhanyu, Wang, Sihui, Yang, Yaning, Zhang, Shuyang, Feng, Xiaoli, Sun, Nan, Wang, Yan, He, Jie
出版 2022

Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)

由 Yang, Guangjian, Xu, Haiyan, Yang, Yaning, Zhang, Shuyang, Xu, Fei, Hao, Xuezhi, Li, Junling, Xing, Puyuan, Hu, Xingsheng, Liu, Yutao, Wang, Lin, Lin, Lin, Wang, Zhijie, Duan, Jianchun, Wang, Jie, Wang, Yan
出版 2022

KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer

由 Liu, Chengming, Zheng, Sufei, Wang, Zhanyu, Wang, Sihui, Wang, Xinfeng, Yang, Lu, Xu, Haiyan, Cao, Zheng, Feng, Xiaoli, Xue, Qi, Wang, Yan, Sun, Nan, He, Jie
出版 2022

EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitors

由 Xu, Haiyan, Yang, Guangjian, Liu, Runze, Yang, Yaning, Li, Weihua, Li, Junling, Hao, Xuezhi, Xing, Puyuan, Wang, Yan
出版 2022

Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences

由 Xu, Fei, Chen, Heng‐chi, Xu, Haiyan, Li, Junling, Hao, Xuezhi, Xing, Puyuan, Ying, Jianming, Wang, Yan
出版 2022

EGFR exon 20 insertion variants A763_Y764insFQEA and D770delinsGY confer favorable sensitivity to currently approved EGFR-specific tyrosine kinase inhibitors

由 Yang, Guangjian, Yang, Yaning, Hu, Jiaqi, Xu, Haiyan, Zhang, Shuyang, Wang, Yan
出版 2022

Treatment patterns and outcomes of immunotherapy in extensive‐stage small‐cell lung cancer based on real‐world practice

由 Yang, Yaning, Ai, Xin, Xu, Haiyan, Yang, Guangjian, Yang, Lu, Hao, Xuezhi, Yang, Ke, Mi, Yuling, Wang, Guizhen, Zhang, Shuyang, Lei, Siyu, Wang, Yan
出版 2022

First‐line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non‐small cell lung cancer with EGFR exon 20 insertions: Real‐world evidence from China...

由 Yang, Guangjian, Yang, Yaning, Liu, Runze, Li, Weihua, Xu, Haiyan, Hao, Xuezhi, Li, Junling, Zhang, Shuyang, Xu, Fei, Lei, Siyu, Wang, Yan
出版 2022